Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Resisted Expiratory Muscle Training for Females Assigned at Birth With Stress Urinary Incontinence: a Pilot Study

NCT07905586 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07905586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Resisted Expiratory Muscle Training for Females Assigned at Birth With Stress Urinary Incontinence: a Pilot Study
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
June 30, 2028
Enrollment
24 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stress urinary incontinence

Arms

As registered; 2 arms.

  • Pelvic floor muscle training Active comparatorPelvic floor muscle training

    Pelvic floor muscle training (PFMT): Participants will be instructed in a home exercise program of PFMT at 5 sets of 5 submaximal repetitions daily. Through the 6 intervention sessions, exercise repetitions will increase to up to 100 per day in gravity dependent positions.

  • Pelvic floor muscle training + expiratory training ExperimentalExpiratory muscle strength training, Pelvic floor muscle training

    Expiratory Muscle Strength Training (EMST): Participants will use a calibrated expiratory resistance device at 50% of MEP, 5 sets of 5 breaths daily.

    PFMT: Participants will be instructed in a home exercise program of PFMT at 5 sets of 5 submaximal repetitions daily. Through the 6 intervention sessions, exercise repetitions will increase to up to 100 per day in gravity dependent positions.

Primary endpoints

Registered primary outcome measures; 2 primary.

  • Attrition This is a post measure after completion of the 7 week study.

    Attrition will be assessed as a feasibility outcome to evaluate participant retention throughout the study. Attrition will be defined as the proportion of enrolled participants who discontinue study participation before completing the final study visit (Visit 7). The attrition rate will be calculated by dividing the number of participants who withdraw or discontinue participation before study completion by the total number of participants enrolled, multiplied by 100. The number and percentage of participants who complete the study will also be reported. Reasons for withdrawal or discontinuation will be documented when available. Attrition and retention rates will be summarized descriptively using counts, percentages, and 95% confidence intervals to evaluate the feasibility of participant retention in the study.

  • Eligibility rates This is a post measure after completion of the 7 week study.

    Eligibility rate will be assessed as a feasibility outcome to evaluate the proportion of individuals screened who meet the study's eligibility criteria. The eligibility rate will be calculated by dividing the number of individuals determined to be eligible by the total number of individuals screened and multiplying by 100. Eligibility will be determined based on the study's prespecified inclusion and exclusion criteria, including an ICIQ-UI SF score of at least 6. The number and percentage of individuals who are eligible and ineligible will be summarized descriptively. Reasons for ineligibility will be documented when available. The eligibility rate will be reported as a percentage with a 95% confidence interval to evaluate the feasibility of identifying an appropriate study population.

Lead sponsor's other trials

Thomas Jefferson University, most recent start first.

Similar trials

Same condition (Urinary Incontinence, Stress) and phase, most recent start first.